Dr Janji

Dr Janji

In January 2017 Sprint Bioscience entered into a research collaboration with Associate Head of Laboratory Bassam Janji at the Department of Oncology, Luxembourg Institute of Health. Dr. Janji’s pioneering research has indicated that autophagy could be a key mechanism for tumor evasion of the immune system. In a joint effort, and using Sprint Bioscience autophagy inhibitors, we investigate cancer immunotherapy and develop anti-cancer drugs that improve tumors’ susceptibility to immune-cell-mediated killing.